SAR441344
Total Payments
$16,240
Transactions
10
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $16,240 | 10 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,066 | 5 | 92.8% |
| Travel and Lodging | $1,018 | 4 | 6.3% |
| Food and Beverage | $155.52 | 1 | 1.0% |
Ad
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $16,240
Product Information
- Type Drug
- Total Payments $16,240
- Total Doctors 2
- Transactions 10
About SAR441344
SAR441344 is a drug associated with $16,240 in payments to 2 healthcare providers, recorded across 10 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2019 to 2019. In 2019, $16,240 was paid across 10 transactions to 2 doctors.
The most common payment nature for SAR441344 is "Consulting Fee" ($15,066, 92.8% of total).